Search

everythinglearnresearchcommunity

for

Search:↓

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Minoxidil and finasteride effectively treat hair loss.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Platelet rich plasma therapy significantly improves hair growth and increases the number of hair follicles in men with androgenetic alopecia.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Cutting scalp biopsies in consecutive slices improves diagnosis of hair loss conditions.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Polarized light therapy helps hair regrowth in alopecia areata patients.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.